MX2020007844A - Camara de biodifusion. - Google Patents
Camara de biodifusion.Info
- Publication number
- MX2020007844A MX2020007844A MX2020007844A MX2020007844A MX2020007844A MX 2020007844 A MX2020007844 A MX 2020007844A MX 2020007844 A MX2020007844 A MX 2020007844A MX 2020007844 A MX2020007844 A MX 2020007844A MX 2020007844 A MX2020007844 A MX 2020007844A
- Authority
- MX
- Mexico
- Prior art keywords
- semi
- permeable membrane
- biodiffusion chamber
- chamber
- permeable
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7088—Compounds having three or more nucleosides or nucleotides
- A61K31/7125—Nucleic acids or oligonucleotides having modified internucleoside linkage, i.e. other than 3'-5' phosphodiesters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M31/00—Devices for introducing or retaining media, e.g. remedies, in cavities of the body
- A61M31/002—Devices for releasing a drug at a continuous and controlled rate for a prolonged period of time
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
- A61M37/0069—Devices for implanting pellets, e.g. markers or solid medicaments
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M39/00—Tubes, tube connectors, tube couplings, valves, access sites or the like, specially adapted for medical use
- A61M39/02—Access sites
- A61M39/0208—Subcutaneous access sites for injecting or removing fluids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
- A61M5/142—Pressure infusion, e.g. using pumps
- A61M5/14244—Pressure infusion, e.g. using pumps adapted to be carried by the patient, e.g. portable on the body
- A61M5/14276—Pressure infusion, e.g. using pumps adapted to be carried by the patient, e.g. portable on the body specially adapted for implantation
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0693—Tumour cells; Cancer cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/13—Tumour cells, irrespective of tissue of origin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M39/00—Tubes, tube connectors, tube couplings, valves, access sites or the like, specially adapted for medical use
- A61M39/02—Access sites
- A61M2039/0205—Access sites for injecting media
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M39/00—Tubes, tube connectors, tube couplings, valves, access sites or the like, specially adapted for medical use
- A61M39/02—Access sites
- A61M39/0208—Subcutaneous access sites for injecting or removing fluids
- A61M2039/0223—Subcutaneous access sites for injecting or removing fluids having means for anchoring the subcutaneous access site
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2206/00—Characteristics of a physical parameter; associated device therefor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
- C12N15/1138—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing against receptors or cell surface proteins
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/10—Type of nucleic acid
- C12N2310/11—Antisense
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/30—Chemical structure
- C12N2310/31—Chemical structure of the backbone
- C12N2310/315—Phosphorothioates
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/30—Chemical structure
- C12N2310/32—Chemical structure of the sugar
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2320/00—Applications; Uses
- C12N2320/30—Special therapeutic applications
- C12N2320/31—Combination therapy
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2320/00—Applications; Uses
- C12N2320/30—Special therapeutic applications
- C12N2320/32—Special delivery means, e.g. tissue-specific
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2320/00—Applications; Uses
- C12N2320/30—Special therapeutic applications
- C12N2320/35—Special therapeutic applications based on a specific dosage / administration regimen
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Genetics & Genomics (AREA)
- Heart & Thoracic Surgery (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- Zoology (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Anesthesiology (AREA)
- Hematology (AREA)
- Wood Science & Technology (AREA)
- Biochemistry (AREA)
- Organic Chemistry (AREA)
- General Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Cell Biology (AREA)
- Dermatology (AREA)
- Virology (AREA)
- Physics & Mathematics (AREA)
- Pulmonology (AREA)
- Biophysics (AREA)
- Plant Pathology (AREA)
- Medical Informatics (AREA)
- Vascular Medicine (AREA)
- Developmental Biology & Embryology (AREA)
- Immunology (AREA)
- Oncology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Se provee una cámara de biodifusión para realizar la vacunación de células autólogas. La cámara de biodifusión está adaptada para insertarse en un sujeto y extraerse del mismo. En algunas modalidades, la cámara de biodifusión comprende (i) un cuerpo de la cámara que define una cavidad hueca e incluye una primera superficie y una segunda superficie, (ii) una primera membrana semipermeable acoplada a la primera superficie, (iii) una segunda membrana semipermeable acoplada a la segunda superficie, y (iv) un elemento y/o característica adaptada para retirar la cámara de biodifusión del sujeto. La primera membrana semipermeable y la segunda membrana semipermeable son permeables a fluidos y factores solubles, pero no son permeables a células. En algunas modalidades, la composición que comprende una cantidad terapéuticamente efectiva de un oligodesoxinucleótido antisentido se inserta en la cámara de biodifusión y se deja difundir hacia fuera de la cámara de biodifusión y hacia dentro del sujeto a través de al menos una de la primera membrana semipermeable o la segunda membrana semipermeable.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201862621295P | 2018-01-24 | 2018-01-24 | |
PCT/US2019/014961 WO2019147817A1 (en) | 2018-01-24 | 2019-01-24 | Biodiffusion chamber |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2020007844A true MX2020007844A (es) | 2021-01-20 |
Family
ID=67394768
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2020007844A MX2020007844A (es) | 2018-01-24 | 2019-01-24 | Camara de biodifusion. |
Country Status (10)
Country | Link |
---|---|
US (1) | US20210052875A1 (es) |
EP (1) | EP3743519A4 (es) |
JP (1) | JP7406213B2 (es) |
KR (1) | KR20200113245A (es) |
CN (1) | CN112204140A (es) |
AU (1) | AU2019212356A1 (es) |
BR (1) | BR112020015028A2 (es) |
CA (1) | CA3089583A1 (es) |
MX (1) | MX2020007844A (es) |
WO (1) | WO2019147817A1 (es) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NZ756820A (en) * | 2017-03-09 | 2022-08-26 | Univ Jefferson | Methods and compositions for treating cancers using antisense |
EP4031465A4 (en) | 2019-09-19 | 2023-09-27 | Thomas Jefferson University | DEVICE AND METHOD FOR BIODIFFUSION CHAMBER STORAGE |
CN111362258A (zh) * | 2020-02-12 | 2020-07-03 | 浙江大学 | 一种蜂蜡作支撑层的石墨烯薄膜转移方法 |
CN113189638B (zh) * | 2021-04-21 | 2024-04-05 | 中国科学院国家空间科学中心 | 一种基于粒子径迹成像云室的粒子运动轨迹成像装置 |
Family Cites Families (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5167638A (en) * | 1989-10-27 | 1992-12-01 | C. R. Bard, Inc. | Subcutaneous multiple-access port |
US5834005A (en) * | 1992-02-24 | 1998-11-10 | Encelle, Inc. | Bioartificial devices and cellular matrices therefor |
US5714170A (en) * | 1994-11-16 | 1998-02-03 | Thomas Jefferson University | Method of inducing resistance to tumor growth |
US6541036B1 (en) * | 1997-05-29 | 2003-04-01 | Thomas Jefferson University | Treatment of tumors with oligonucleotides directed to insulin-like growth factor-I receptors (IGF-IR) |
IL134009A (en) * | 2000-01-12 | 2011-07-31 | Bo2 Technologies Ltd | Transplant device |
US7037335B2 (en) * | 2002-11-19 | 2006-05-02 | Eagle Vision, Inc. | Bulbous scleral implants for the treatment of eye disorders such as presbyopia and glaucoma |
US7361168B2 (en) * | 2004-04-21 | 2008-04-22 | Acclarent, Inc. | Implantable device and methods for delivering drugs and other substances to treat sinusitis and other disorders |
EP2240155B1 (en) * | 2008-02-13 | 2012-06-06 | Intarcia Therapeutics, Inc | Devices, formulations, and methods for delivery of multiple beneficial agents |
US9446168B2 (en) * | 2010-06-07 | 2016-09-20 | Beta-O2 Technologies Ltd. | Multiple-layer immune barrier for donor cells |
FI123146B (fi) * | 2009-10-01 | 2012-11-30 | Bayer Schering Pharma Oy | Kohdunsisäinen järjestelmä |
CN103228229B (zh) * | 2010-09-27 | 2015-11-25 | Ns基因公司 | 具有支持和径向扩散支架的可植入细胞装置 |
CN105142570B (zh) * | 2013-04-24 | 2018-06-22 | 雀巢产品技术援助有限公司 | 包封装置 |
SG11201602232UA (en) * | 2013-09-24 | 2016-04-28 | Giner Inc | System for gas treatment of a cell implant |
CA2923092C (en) * | 2014-01-03 | 2019-12-17 | Koninklijke Philips N.V. | Assessment of the pi3k cellular signaling pathway activity using mathematical modelling of target gene expression |
US9872674B2 (en) * | 2014-05-07 | 2018-01-23 | Boehringer Laboratories Inc. | Entrapment and containment system for use with a morcellator and method of entrapping and containing material produced during morcellation procedure |
CN108260357A (zh) * | 2015-04-10 | 2018-07-06 | 托马斯杰弗逊大学 | 用于通过选择性减少免疫调节m2单核细胞治疗癌症及增强治疗性免疫力的方法和组合物 |
KR20240017123A (ko) * | 2015-04-23 | 2024-02-06 | 어플라이드 메디컬 리소시스 코포레이션 | 조직 제거를 위한 시스템들 및 방법들 |
NZ756820A (en) * | 2017-03-09 | 2022-08-26 | Univ Jefferson | Methods and compositions for treating cancers using antisense |
CA3118424A1 (en) * | 2018-11-02 | 2020-05-07 | Thomas Jefferson University | Methods and compositions for treating hepatocellular carcinoma using antisense |
EP4031465A4 (en) * | 2019-09-19 | 2023-09-27 | Thomas Jefferson University | DEVICE AND METHOD FOR BIODIFFUSION CHAMBER STORAGE |
WO2021188814A1 (en) * | 2020-03-18 | 2021-09-23 | Millennium Pharmaceuticals, Inc. | Implantable cell chamber device and uses thereof |
CN115697300A (zh) * | 2020-04-09 | 2023-02-03 | 帝梵麦德公司 | 用于医疗装置的膜 |
-
2019
- 2019-01-24 US US16/964,693 patent/US20210052875A1/en active Pending
- 2019-01-24 AU AU2019212356A patent/AU2019212356A1/en active Pending
- 2019-01-24 KR KR1020207024375A patent/KR20200113245A/ko not_active Application Discontinuation
- 2019-01-24 WO PCT/US2019/014961 patent/WO2019147817A1/en unknown
- 2019-01-24 EP EP19744113.2A patent/EP3743519A4/en active Pending
- 2019-01-24 BR BR112020015028-2A patent/BR112020015028A2/pt unknown
- 2019-01-24 MX MX2020007844A patent/MX2020007844A/es unknown
- 2019-01-24 JP JP2020562074A patent/JP7406213B2/ja active Active
- 2019-01-24 CN CN201980016592.7A patent/CN112204140A/zh active Pending
- 2019-01-24 CA CA3089583A patent/CA3089583A1/en active Pending
Also Published As
Publication number | Publication date |
---|---|
US20210052875A1 (en) | 2021-02-25 |
EP3743519A4 (en) | 2022-02-23 |
CN112204140A (zh) | 2021-01-08 |
BR112020015028A2 (pt) | 2020-12-29 |
JP7406213B2 (ja) | 2023-12-27 |
JP2021511832A (ja) | 2021-05-13 |
EP3743519A1 (en) | 2020-12-02 |
CA3089583A1 (en) | 2019-08-01 |
AU2019212356A1 (en) | 2020-08-13 |
KR20200113245A (ko) | 2020-10-06 |
WO2019147817A1 (en) | 2019-08-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2020007844A (es) | Camara de biodifusion. | |
HK1144078A1 (en) | Method for preparing porous scaffold for tissue engineering | |
CL2010000710A1 (es) | Uso de una canula para la irradiacion de un objetivo en un ojo,en que la canula esta configurada ser insertada en un espacio potencial debajo de la capsula de tenon del ojo, la insercion de la canula permite la observacion a traves de la pupila, puede ser ajustada y permite la irradiacion del objetivo con rbs. | |
DK2257496T3 (da) | System og fremgangsmåde til dyrkning af nanorør ved ionimplantering under anvendelse af en katalytisk transmembran | |
NZ615383A (en) | Methods and devices for cellular transplantation | |
PH12018500371A1 (en) | Clinical formulations | |
WO2012006072A3 (en) | Air impedance electrospinning for controlled porosity | |
WO2007106868A3 (en) | Cell culture devices having ultrathin porous membrane and uses thereof | |
AR052640A1 (es) | Capsula para preparar una bebida ,dispositivo y procedimiento para la extraccion de dicha bebida al inyectar un fluido presurizado en la capsula y metodo de fabricacion de la capsula. | |
NZ609731A (en) | Compositions of adult organ stem cells and uses thereof | |
WO2004096975A3 (en) | Apparatus and methods for amplification of blood stem cell numbers | |
EP2138181A4 (en) | METHOD FOR THE PRODUCTION OF DECCELLULATED SOFT TISSUE, GRAFT PROSTHESIS AND CULTURAL MATERIAL | |
WO2010111522A3 (en) | Mesenchymal stem cells producing inhibitory rna for disease modification | |
MX357746B (es) | Uso de células t de memoria central anti-tercera parte para el tratamiento anti-leucemia/linfoma. | |
WO2004072248A3 (en) | A process for delivering sirna to cardiac muscle tissue | |
IL277025B1 (en) | Methods for improving the differentiation of stem cells into beta cells | |
DK1307247T3 (da) | Kollagenmembran, der er anordnet på makromolekylært niveau | |
WO2012052872A3 (en) | Methods and compositions for the treatment of insulin-associated medical conditions | |
MX2018007986A (es) | Terapia genica para epidermolisis ampollosa distrofica recesiva con queratinocitos autologos geneticamente corregidos. | |
MX2012014619A (es) | Filtro de flujo para separar sangre en plasma y constituyentes celulares. | |
GB2526957A (en) | System and method to efficiently clean a blood filter | |
TW200501924A (en) | Implantable pouch seeded with insulin-producing cells to treat diabetes | |
AR079710A1 (es) | Proceso para el cultivo de celulas adherentes | |
GB2562920A (en) | Devices, methods, and compositions for restricting cell position and stabilizing cells in culture systems | |
WO2019022393A3 (ko) | 나노다공성 투과막이 부착된 3차원 세포배양용 마이크로 칩 및 그의 제조방법 |